Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C30H30F2N6O3 |
Molecular Weight | 560.5944 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
Stereo Comments | AXIAL, R |
SHOW SMILES / InChI
SMILES
CC(C)C1=NC=CC(C)=C1N2C(=O)N=C(N3CCN(C[C@@H]3C)C(=O)C=C)C4=C2N=C(C(F)=C4)C5=C(F)C=CC=C5O
InChI
InChIKey=NXQKSXLFSAEQCZ-SFHVURJKSA-N
InChI=1S/C30H30F2N6O3/c1-6-23(40)36-12-13-37(18(5)15-36)28-19-14-21(32)26(24-20(31)8-7-9-22(24)39)34-29(19)38(30(41)35-28)27-17(4)10-11-33-25(27)16(2)3/h6-11,14,16,18,39H,1,12-13,15H2,2-5H3/t18-/m0/s1
Molecular Formula | C30H30F2N6O3 |
Molecular Weight | 560.5944 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:33:40 GMT 2023
by
admin
on
Sat Dec 16 14:33:40 GMT 2023
|
Record UNII |
2B2VM6UC8G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
654918
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
||
|
FDA ORPHAN DRUG |
653818
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2B2VM6UC8G
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
PRIMARY | |||
|
137278711
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
PRIMARY | |||
|
2252403-56-6
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
2B2VM6UC8G
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
PRIMARY | |||
|
HI-164
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
PRIMARY | |||
|
Sotorasib
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
PRIMARY | |||
|
2296729-00-3
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
PRIMARY | |||
|
DB15569
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
PRIMARY | |||
|
11370
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
PRIMARY | |||
|
100000183068
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
PRIMARY | |||
|
C154287
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
PRIMARY | |||
|
DTXSID001099260
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
PRIMARY | |||
|
2550714
Created by
admin on Sat Dec 16 14:33:41 GMT 2023 , Edited by admin on Sat Dec 16 14:33:41 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> INHIBITOR |
IC50
|
||
|
PROTEIN ADDUCT FORMATION |
|
||
|
OFF-TARGET->INHIBITOR |
Weak Inhibitor
|
||
|
TARGET -> INHIBITOR |
Selective for G12C mutant. Approved to target KRAS G12C mutations in the second-line setting.
IRREVERSIBLE INHIBITOR
IC50
|
||
|
TRANSPORTER -> INHIBITOR |
IC50
|
||
|
EXCRETED UNCHANGED |
FECAL
|
||
|
TRANSPORTER -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TRANSPORTER -> INHIBITOR |
IC50
|
||
|
BINDER->LIGAND |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE LESS ACTIVE -> PARENT |
IRREVERSIBLE INHIBITOR
IC50
|
||
|
METABOLITE INACTIVE -> PARENT |
|
||
|
METABOLITE INACTIVE -> PARENT |
Mediated primarily by nonenzymatic
glutathione conjugation
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
||||
Biological Half-life | PHARMACOKINETIC |
|